PUBLIC CONTRACT · 2020

Medicamentos Nevirapina, Tenofovir, Emtricit+Tenofovir, Abacav+Lami (SPMS)

Contract value
€33,200.36
Signed on
16 December 2020
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 7500584

PUBLISHED SUBJECT

41/42/2021 - Medicamentos Nevirapina, Tenofovir, Emtricit+Tenofovir, Abacav+Lami (SPMS)

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
GENERIS - FARMACEUTICA, S.A. · Tax ID 508107997
Awardee
KRKA FARMACEUTICA · Tax ID 507981227

Values and timeline

Contract price
€33,200.36
Procedure base price
€256,633.76
Total effective price
Not reported on Portal BASE
Publication date
25 February 2021
Award date
16 December 2020
Signing date
16 December 2020
Performance period
60 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
Framework agreement
CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5158336

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts